Genomic Health Inc (GHDX) Return on Assets ROA from the third quarter of 2019 to third quarter of 2018 and for the year 2019, Average High and Low, Fundamental Ratios from Sep 30 2019 to Sep 30 2018 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Genomic Health Inc  (NASDAQ: GHDX)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Genomic Health Inc's ROA from the third quarter of 2019 to the third quarter of 2018 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Genomic Health Inc's ROA in the third quarter of 2019?
Genomic Health Inc achieved a return on average assets (ROA) of 14.03 % in its third quarter of 2019 a new company high.

ROA has improved compared to 13.79% in the second quarter of 2019, due to net income growth.

However, within the Healthcare sector 67 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2019 quarter, so far to 400, from total ROA ranking in the second quarter of 2019 at 458.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Total Assets Change 53.28 % 58.42 % 61.68 % 44.36 % 35.02 %
Y / Y Net Income Change 52.92 % 92.22 % - 374.19 % -
Net Income (TTM) in million 57 50 42 26 19
Return On Assets (TTM) 14.03 % 13.79 % 13.1 % 8.96 % 7.14 %
GHDX's Total Ranking # 400 # 458 # 880 # 1036 # 2153
Total Assets (TTM) in million 460 426 393 334 300
Seq. Total Assets Change 8.04 % 8.5 % 17.47 % 11.32 % 11.65 %
Seq. Net Income Change 16.93 % 22.99 % 45.89 % -27.12 % 46.99 %

GHDX's 5 Years Annual ROA >> Back to GHDX Management Effectiveness >> Compare GHDX ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 2
Sector # 68
Overall # 371

Return On Assets Statistics
High Average Low
14.03 %
-4.72 %
-19.42 %
(Sep 30 2019)   (Sep 30 2015)





Financial Statements
Genomic Health Inc's Assets $ 460 million GHDX's Balance sheet
Genomic Health Inc's Income $ 19 million Quarterly GHDX's Income Statement
GHDX's Income by Division See GHDX's Income by Division



Annual Return On Assets (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017		 (Dec 31 2016)
FY 2016		 (Dec 31 2015)
FY 2015		 (Dec 31 2014)
FY 2014
Y / Y Total Assets Change 44.36 % 15.17 % 8.94 % -0.7 % 5.02 %
Total Assets in million 334 232 201 185 186
Y / Y Net Income Change - - - - -
Net Income in million 26 -4 -14 -33 -25
Annual Return On Assets 7.68 % -1.67 % -6.92 % -18.04 % -13.23 %

GHDX's 5 Years Annual ROA >> Back to GHDX Management Effectiveness >> Compare GHDX ROA to its Competitors



Comment on GHDX's ROA in the fiscal year ending 2018
In the fiscal year 2018 ROA improved to 7.68 % compared to prior year, due to annual net income growth of % to $25.68 million, while value of Genomic Health Inc's overall assets grew just by 44.36 % to $334.37 million, compared to $334.37 a year before.


More Return On Assets Ratios
GHDX's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
GHDX's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for GHDX's Competitors
Subscribers only: Roa for Genomic Health Inc's Suppliers
Subscribers only: Return On Assets for GHDX's Customers

You may also want to know
GHDX's Roi GHDX's Inventory Turnover Ratio GHDX's Growth Rates GHDX's Dividend Comparisons
GHDX's Profitability Ratios GHDX's Asset Turnover Ratio GHDX's Dividend Growth
GHDX's Roe GHDX's Valuation Ratios GHDX's Financial Strength Ratios GHDX's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2019, within Healthcare Sector ROA
Exelixis Inc   38.32 %
Ligand Pharmaceuticals Incorporated  36.43 %
Oramed Pharmaceuticals Inc  35.60 %
Vanda Pharmaceuticals Inc   31.81 %
Orgenesis Inc   31.38 %
Vertex Pharmaceuticals Inc  31.00 %
Strongbridge Biopharma plc  29.96 %
Nrc Health  29.69 %
Biocorrx Inc   28.44 %
Remedent Inc   28.29 %
Corcept Therapeutics Inc  26.15 %
Harrow Inc   26.14 %
Idexx Laboratories Inc  25.50 %
Siga Technologies Inc  24.34 %
Arrowhead Pharmaceuticals Inc   24.01 %
Biospecifics Technologies Corp  21.86 %
Mettler toledo International Inc   20.83 %
Abiomed Inc   20.73 %
Biogen Inc   20.45 %
Eli Lilly And Company  20.06 %
Alpha Pro Tech Ltd   19.81 %
Chemed Corporation  19.09 %
Waters Corporation  18.66 %
Align Technology inc   18.65 %
Regeneron Pharmaceuticals Inc   16.59 %
Fonar Corporation  16.05 %
Pro dex Inc   15.76 %
Masimo Corp  15.60 %
Intuitive Surgical Inc   15.53 %
Celgene Corp  15.31 %

Date modified: 2026-09-26T07:02:50+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.